Massachusetts Financial Services Co. MA purchased a new stake in Owens & Minor, Inc. (NYSE:OMI – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 100,823 shares of the company’s stock, valued at approximately $1,582,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of OMI. Deerfield Management Company L.P. Series C raised its stake in Owens & Minor by 30.6% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock worth $86,014,000 after acquiring an additional 1,493,852 shares in the last quarter. Foundry Partners LLC purchased a new stake in shares of Owens & Minor during the third quarter worth approximately $5,238,000. Renaissance Technologies LLC lifted its stake in shares of Owens & Minor by 16.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock worth $16,829,000 after acquiring an additional 176,250 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of Owens & Minor by 374.2% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 223,074 shares of the company’s stock valued at $3,500,000 after acquiring an additional 176,029 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in Owens & Minor by 1.9% during the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock worth $242,459,000 after purchasing an additional 162,182 shares in the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.62% of the company’s stock.
Analyst Upgrades and Downgrades
Owens & Minor Trading Up 0.9 %
NYSE OMI opened at $13.31 on Thursday. The company has a market cap of $1.03 billion, a P/E ratio of -20.48, a P/E/G ratio of 0.47 and a beta of 0.41. Owens & Minor, Inc. has a 12 month low of $11.42 and a 12 month high of $28.35. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The company has a 50-day moving average of $13.65 and a 200-day moving average of $15.09.
Owens & Minor (NYSE:OMI – Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.41 by $0.01. The firm had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. Owens & Minor’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 earnings per share. As a group, equities analysts predict that Owens & Minor, Inc. will post 1.49 earnings per share for the current year.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Read More
- Five stocks we like better than Owens & Minor
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the FTSE 100 index?
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI – Free Report).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.